S
Shayan Nabavi Nouri
Researcher at NewYork–Presbyterian Hospital
Publications - 8
Citations - 374
Shayan Nabavi Nouri is an academic researcher from NewYork–Presbyterian Hospital. The author has contributed to research in topics: Clinical endpoint & Pulmonary embolism. The author has an hindex of 4, co-authored 6 publications receiving 210 citations.
Papers
More filters
Journal ArticleDOI
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Behnood Bikdeli,Behnood Bikdeli,Mahesh V. Madhavan,Aakriti Gupta,Aakriti Gupta,David Jiménez,John R. Burton,Caroline Der Nigoghossian,Taylor Chuich,Shayan Nabavi Nouri,Isaac Dreyfus,Elissa Driggin,Sanjum S. Sethi,Kartik Sehgal,Kartik Sehgal,Saurav Chatterjee,Walter Ageno,Mohammad Madjid,Yutao Guo,Yutao Guo,Liang V. Tang,Yu Hu,Laurent Bertoletti,Jay Giri,Jay Giri,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Alfonso Tafur,Alfonso Tafur,Dominic P. Francese,Jaya Batra,Anna Falanga,Kevin J. Clerkin,Nir Uriel,Ajay J. Kirtane,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,Ido Weinberg,Sam Schulman,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,Martin B. Leon,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +65 more
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Journal ArticleDOI
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.
Aakriti Gupta,Mahesh V. Madhavan,Timothy J. Poterucha,Ersilia M. DeFilippis,Jessica A. Hennessey,Björn Redfors,Björn Redfors,Christina Eckhardt,Behnood Bikdeli,Behnood Bikdeli,Jonathan Platt,Ani Nalbandian,Pierre Elias,Matthew J. Cummings,Shayan Nabavi Nouri,Matthew Lawlor,Lauren S. Ranard,Jianhua Li,Claudia Boyle,Raymond Givens,Daniel Brodie,Harlan M. Krumholz,Gregg W. Stone,Sanjum S. Sethi,Daniel Burkhoff,Nir Uriel,Allan Schwartz,Martin B. Leon,Ajay J. Kirtane,Elaine Wan,Sahil A. Parikh +30 more
TL;DR: In this article, a multivariable logistic regression model was constructed to predict the propensity of receiving statins, adjusting for baseline sociodemographic and clinical characteristics, and outpatient medications.
Posted ContentDOI
Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19
Aakriti Gupta,Mahesh V. Madhavan,Timothy J. Poterucha,Ersilia M. DeFilippis,Jessica A. Hennessey,Björn Redfors,Christina Eckhardt,Behnood Bikdeli,Jonathan Platt,Ani Nalbandian,Pierre Elias,Matthew J. Cummings,Shayan Nabavi Nouri,Matthew Lawlor,Lauren S. Ranard,Jianhua Li,Claudia Boyle,Raymond Givens,Daniel Brodie,Harlan M. Krumholz,Gregg W. Stone,Sanjum S. Sethi,Daniel Burkhoff,Nir Uriel,Allan Schwartz,Martin B. Leon,Ajay J. Kirtane,Elaine Wan,Sahil A. Parikh +28 more
TL;DR: It is concluded that antecedent statin use in patients hospitalized with COVID-19 was associated with lower inpatient mortality, and Randomized clinical trials evaluating the utility of statin therapy in patients with CO VID-19 are needed.
Journal ArticleDOI
Preprint manuscripts and servers in the era of coronavirus disease 2019.
Shayan Nabavi Nouri,Yosef A. Cohen,Mahesh V. Madhavan,Piotr J. Slomka,Ami E. Iskandrian,Andrew J. Einstein +5 more
TL;DR: While vital in the rapid dispensation of science, preprint manuscripts promulgate their conclusions without peer review and possess the capacity to misinform.
Journal ArticleDOI
Impella percutaneous left ventricular assist device as mechanical circulatory support for cardiogenic shock: A retrospective analysis from a tertiary academic medical center.
Shayan Nabavi Nouri,Waqas Malick,Amirali Masoumi,Justin Fried,Veli K. Topkara,Michael I. Brener,Yousif Ahmad,Megha Prasad,LeRoy E. Rabbani,Koji Takeda,Dimitrios Karmpaliotis,Jeffrey W. Moses,Martin B. Leon,Ajay J. Kirtane,A. Reshad Garan +14 more
TL;DR: Hemodynamic efficacy and clinical outcomes of Impella percutaneous left ventricular assist device (pLVAD) in patients with cardiogenic shock (CS) are described.